Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
08 December 2020 | Story Leonie Bolleurs | Photo Supplied
At the BJCP beer judging competition, Dr Errol Cason won Best of Show with his Belgian Saison. Here he is presenting at the AfricaBrew2020 Brewing conference.

Staff and students from the University of the Free State (UFS) once again proved their skills in beer homebrewing when they walked away with one first place and two second places at the 13th annual Anheuser-Busch Inbev (AB-Inbev) – formally South African Breweries (SAB) – intervarsity beer brewing and tasting competition, and the Beer Judging Certification Programme (BJCP) competition held at the AfricaBrew2020 Brewing conference. Both these events took place over the weekend of 27 and 28 November 2020.

Evil Twin Double and Three Sips German 

Competing in the AB-Inbev/SAB Intervarsity brewing and tasting competition, was a group of students from the UFS Department of Microbial, Biochemical and Food Biotechnology, consisting of Eduvan Bischoff (PhD student), Elzette van der Walt (MSc student), Culien van der Merwe (MSc student), Gunther Staats (MSc student), and Twyne Skein (MSc student). This team came second in both the Indian Pale Ale (IPA) category with their Evil Twin Double IPA and in the Lager category with their Three Sips German Pils. 

“This is an outstanding accomplishment. Congratulations also go to our fellow Free Stater’s at the Central University of Technology (CUT) for winning the India Pale Ale (IPA) category as well as best overall beer with their New England IPA,” commented Dr Errol Cason, Senior Lecturer in the UFS Department of Animal Science, also representing the liquid yeast company LiquidCulture Yeast.

According to Dr Cason, this SAB-sponsored competition sees students from local universities brew and enter beers for judging, and competing for prizes, including the coveted ‘Best of Show’ trophy. 

“This event also aims to promote beer culture along with responsible drinking, by hosting talks by industry experts where students can interact with commercial brewers, scientists, and marketers,” says Dr Cason. 

The event was hosted by South African Breweries (SAB) and CUT, through the Centre for Applied Food Sustainability and Biotechnology (CAFSaB), in association with the UFS. 

Although the event was moved online in 2020 due to the international pandemic, it did not mean that there was a decline in the quality of presentations, or in the beer entered by universities. – D r Errol Cason

Dr Cason explains that entrants are usually challenged to brew beers according to the 2015 Beer Judge Certification Programme (BJCP) guidelines in lager, IPA, winter warmer, and fruit beer categories. 

“This year included the African Premium Ale and Lockdown Brew categories as well, where teams were mostly left to invent and experiment on their own with a few rules, such as using only indigenous African ingredients or ingredients that were available in supermarkets during lockdown,” says Dr Cason. 

There is also an award for the best bottle dress (label). 

Dr Cason believes that although the event was moved online in 2020 due to the international pandemic, it did not mean that there was a decline in the quality of presentations, or in the beer entered by universities. 

Belgian Saison and Extra Special Bitter

He and Christopher Rothmann, who is busy with a PhD in Biotechnology at the UFS and is co-founder of the company LiquidCulture (LC) Yeast, attended and presented at the AfricaBrew2020 Brewing conference. AfricaBrew is an annual brewing conference specialising in workshops and demonstrations for home and professional brewers. 

Accompanying the conference is a BJCP beer judging competition where all home and professional brewers can enter beers. During this competition, Dr Cason won Best of Show with his Belgian Saison. Rothmann came second with his Extra Special Bitter.

Since LiquidCulture Yeast was found in 2018, this commercial venture has since spun out and are now providing liquid brewing yeast to the homebrewing and commercial brewing industry. Rothmann and Dr Cason are also founding members of the Kovsie Brewery (along with Dr Jan-G Vermeulen and Eduan Hellmuth), which is currently being constructed on the UFS Paradys Experimental Farm facility.

News Archive

UFS researcher explores the future cost of cancer
2017-01-10

 Description: 001 Dr Alicia Sherriff Tags: 001 Dr Alicia Sherriff

Dr Alicia Sherriff, Head the Department of Oncology
at the UFS Faculty of Health Sciences, co-authored
an article in the South African Medical Journal.

Photo: Charl Devenish

Cancer is on an exponential rise globally, and the cost of treatment is a growing international problem. South Africa alone is expected to see a 78% increase in cancer cases. Dr Alicia Sheriff, Head of the Department of Oncology, collaborated on and co-authored a research paper for the South African Medical Journal on the future of oncology treatment in the country, along with doctors from various universities across South Africa. The article, titled "The future cost of cancer: interdisciplinary cost management strategy", looks at the prognosis of cancer management in the country.

Cancer is on the rise

There is a visible growth of the cancer disease in the developing world. Rapidly changing lifestyles, uncontrolled urbanisation, pollution, and population ageing are some dynamics that provide a lethal cocktail of infectious and lifestyle risk factors that leave people at a higher risk of developing cancer.

The simultaneous increase in cancer incidence has increased the cost of treatment exponentially. The cost of cancer treatment is multitiered, making the provision of care for cancer patients a high-risk business. A combination of treatment delays, limited resources, differently skilled personnel, high patient volumes and advanced disease stage on presentation all place a bigger burden on the delivery of optimal cancer care outcomes.

Adoption of new strategies

According to the doctors, innovative thinking to embrace technology, combined with a preventive approach, as well as lowering the cost of treatment drugs should be prioritised. So should the commercialisation of new technologies that will diagnose and treat cancer in its early stages. They also encourage interdisciplinary research funding in South Africa as a way to better understand the demographic and molecular dynamics of cancer in the country, along with retaining more oncologists in the public health sector.

Efficient solutions to curb cancer mortality

The doctors assert there is a need to continue to look for more efficient measures to best treat the disease, and hopefully bring about a change in mortality levels in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept